Osaic Holdings’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.2K Sell
952
-181
-16% -$4.93K ﹤0.01% 5574
2025
Q4
$30.8K Buy
1,133
+385
+51% +$10.1K ﹤0.01% 5572
2025
Q3
$18.9K Buy
748
+83
+12% +$1.92K ﹤0.01% 5965
2025
Q2
$13.4K Buy
665
+408
+159% +$7.94K ﹤0.01% 5979
2025
Q1
$4.66K Sell
257
-208
-45% -$4.65K ﹤0.01% 6223
2024
Q4
$11.7K Sell
465
-26
-5% -$706 ﹤0.01% 5678
2024
Q3
$16.7K Sell
491
-198
-29% -$7.54K ﹤0.01% 5487
2024
Q2
$25.5K Sell
689
-71
-9% -$2.68K ﹤0.01% 5170
2024
Q1
$31.9K Buy
760
+213
+39% +$8.75K ﹤0.01% 5057
2023
Q4
$21.7K Sell
547
-146
-21% -$4.29K ﹤0.01% 5453
2023
Q3
$19.1K Sell
693
-117
-14% -$3.67K ﹤0.01% 5588
2023
Q2
$27.5K Sell
810
-98
-11% -$3.3K ﹤0.01% 5351
2023
Q1
$32.7K Sell
908
-57
-6% -$2.46K ﹤0.01% 5260
2022
Q4
$42K Sell
965
-69
-7% -$2.46K ﹤0.01% 5057
2022
Q3
$29K Sell
1,034
-10
-1% -$307 ﹤0.01% 5313
2022
Q2
$28K Buy
1,044
+66
+7% +$1.92K ﹤0.01% 5372
2022
Q1
$32K Buy
978
+39
+4% +$1.25K ﹤0.01% 5397
2021
Q4
$37K Buy
939
+27
+3% +$1.18K ﹤0.01% 5365
2021
Q3
$49K Sell
912
-10
-1% -$469 ﹤0.01% 5120
2021
Q2
$31K Hold
922
﹤0.01% 5384
2021
Q1
$18K Sell
922
-13
-1% -$299 ﹤0.01% 5546
2020
Q4
$16K Sell
935
-399
-30% -$7.18K ﹤0.01% 5282
2020
Q3
$20K Buy
1,334
+13
+1% +$152 ﹤0.01% 4900
2020
Q2
$17K Buy
1,321
+367
+38% +$1.63K ﹤0.01% 4889
2020
Q1
$1K Buy
+954
New +$2.16K ﹤0.01% 5808

Other funds holding CLDX